Brio College Prep, part of the Ednovate charter school network, celebrated its move into new educational facilities with a ...
A partnership program with the Children's Aid Foundation of Canada, child welfare organizations and school boards aims to ...
MedPage Today on MSN
PAM Inhibitor Doubles Time to Progression in Advanced Breast Cancer Subset
Novel gedatolisib is currently under review at FDA for wild-type patients ...
Gedatolisib plus fulvestrant and palbociclib (the “gedatolisib-triplet”) reduced the risk of disease progression or death by 50% vs. alpelisib ...
Notably, the clinical trials MAGMA and JCOG1703 further demonstrated that some treatment regimens for newly diagnosed GBMs ...
MedPage Today on MSN
Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy
ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...
Low-dose aspirin during adjuvant chemotherapy did not significantly reduce risk for recurrence among unselected patients with ...
The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
These results support darovasertib plus Xalkori as a potential new standard of care if approved for HLA A*02:01-negative ...
A partnership program with the Children's Aid Foundation of Canada, child welfare organizations and school boards aims to ...
Immuneering Corporation ( IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer June 1, 2026 8:00 AM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results